The Food and Drug Administration is scrambling to bring back hundreds of critical workers laid off en masse by DOGE.
Medical Device Network on MSN7h
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetesThe US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in individuals aged 18 and above with type 2 ...
Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
Google just announced it’s received FDA clearance for the Pixel Watch 3’s Loss of Pulse Detection feature. It will start ...
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back. Beginning Friday night, FDA ...
Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S ...
But much will depend on how quickly and effectively the funds are deployed, if regulatory bottlenecks are eased, and how ...
Continuous glucose monitors are becoming popular among the health-conscious. But a small study found a CGM overestimated ...
The firm is focusing on specialty chronic therapies like immunotherapy, antibody-drug conjugates, and gene therapy drugs, ...
Aspargo Labs, Inc. ("Aspargo Labs” or the "Company”), a specialty pharmaceutical and MedTech company focused on converting ...
Traditional screening methods rely on biochemical tests, such as tandem mass spectrometry, which detect metabolic imbalances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback